94563-4

SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

Active

Term Description

Detection of SARS-CoV-2 IgG antibodies by an immunoassay method, such as enzyme-linked immunosorbent assay. This test is used in conjunction with SARS-CoV-2 IgA and IgM to aid in the diagnosis of COVID-19 and in the identification of individuals infected with SARS-CoV-2.

Part Description

LP417540-4   SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.

The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Source: LOINC

LOINC Names Get Info

Fully-Specified Name

SARS coronavirus 2 Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IA

Long Common Name

SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

Short Name

SARS-CoV-2 IgG SerPl Ql IA

Display Name

SARS-CoV-2 (COVID-19) IgG IA Ql

Consumer Name Alpha Get Info

SARS-CoV-2 (COVID-19) IgG antibody, Blood

Part Model Get Info

• Component

  SARS coronavirus 2 Ab.IgG
  LP417915-8

  • Analyte

    SARS coronavirus 2 Ab.IgG
    LP417915-8

    • Component Numerator

      SARS coronavirus 2 Ab.IgG
      LP417915-8

      • Component Numerator Core

        SARS coronavirus 2
        LP417540-4

      • Component Numerator Core Suffix

        Ab.IgG
        LP32401-9

    • Component Denominator

      NULL
       

      • Component Denominator Core

        NULL
         

      • Component Denominator Core Suffix

        NULL
         

  • Challenge

    NULL
     

  • Adjustment

    NULL
     

  • Count

    NULL
     

• Property

  PrThr
  LP217195-9

• Time

  Pt
  LP6960-1

  • Time Core

    Pt
    LP6960-1

  • Time Modifier

    NULL
     

• System

  Ser/Plas
  LP7576-4

  • System Core

    Ser/Plas
    LP7576-4

  • Super System

    NULL
     

• Scale

  Ord
  LP7751-3

• Method

  IA
  LP217197-5

Ask at Order Entry

Example Answer List: LL2009-0

Basic Attributes

Class

MICRO

Type

Laboratory

First Released

Version 2.68

Last Updated

Version 2.73 (MIN)

Order vs. Observation

Both

Common Test Rank Get Info

5960

Member of these Panels

Member of these Groups Get Info

Language Variants Get Info

Related Names

• 2019 Novel Coronavirus
• 2019-nCoV
• ABS
• Aby
• Antby
• Anti
• Antibodies
• Antibody
• Autoantibodies
• Autoantibody
• Corona virus
• COVID19
• COVID-19
• EIA
• ELFA
• ELISA
• Enzyme immunoassay
• IAA
• ID
• II
• Immune globulin G
• Immunoglobulin G
• Infectious Disease
• InfectiousDisease
• MEIA
• Microbiology
• Ordinal
• Pl
• Plasma
• Plsm
• Point in time
• PR
• QL
• Qual
• Qualitative
• Random
• SARS Coronavirus 1
• SARS-CoV
• SARS-CoV-1
• SARS-CoV-2
• Screen
• SerP
• SerPl
• SerPlas
• Serum
• Serum or plasma
• Severe Acute Respiratory Syndrome
• SR
• SUDS
• Viral Pneumonias
• Wuhan coronavirus

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.

CodeSystem lookup

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=94563-4

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to https://www.snomed.org/get-snomed or [email protected]<mailto:[email protected]>. This may incur a fee in SNOMED International non-Member countries.

LOINC Copyright

Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.